OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at HC Wainwright from $40.00 to $34.00. They now have a "buy" rating on the stock.
Will OnKure Therapeutics (NASDAQ:OKUR) Spend Its Cash Wisely? [Yahoo! Finance]
OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $30.00. They now have an "outperform" rating on the stock.
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences